Holen Sie sich die Stockscreener-App
0.3293
6.16%
0.0191
Handel nachbörslich:
.32
-0.0093
-2.82%
Schlusskurs vom Vortag:
$0.3102
Offen:
$0.3155
24-Stunden-Volumen:
2.74M
Relative Volume:
0.31
Marktkapitalisierung:
$23.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.08M
KGV:
-0.1526
EPS:
-2.1574
Netto-Cashflow:
$-72.06M
1W Leistung:
-36.13%
1M Leistung:
-55.44%
6M Leistung:
-84.01%
1J Leistung:
-66.05%
1-Tages-Spanne:
$0.3054
$0.3348
1-Wochen-Bereich:
$0.2053
$0.5792
52-Wochen-Spanne:
$0.2053
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Firmenname
Io Biotech Inc
Sektor
Branche
Telefon
(457) 070-2980
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Vergleichen Sie IOBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.3293 | 22.32M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | Herabstufung | TD Cowen | Buy → Hold |
Io Biotech Inc Aktie (IOBT) Neueste Nachrichten
Is IO Biotech Inc. a top pick in the sectorWeekly Trend Recap & Daily Volume Surge Signals - mfd.ru
Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com
Piper Sandler Downgrades IO Biotech (IOBT) to Neutral, Lowers Pr - GuruFocus
IO Biotech stock rating downgraded by Piper Sandler amid strategic review - Investing.com Canada
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - MSN
Aug Decliners: Is IO Biotech Inc a potential multi baggerMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
IOBT IO Biotech, Inc. (NASDAQ) $0.47 on 22 Jan 2026: active intraday mover for traders - Meyka
IO Biotech’s Future Uncertain As Cylembio Cloud Remains - Citeline News & Insights
IO Biotech Begins Review Of Strategic Options As Cash Runway Narrows - Nasdaq
IO Biotech weighs strategic options months after FDA advises against melanoma vaccine filing - European Biotechnology Magazine
IO Biotech admits defeat | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Listed Danish biotech company fights for survival after FDA rejection and failed capital raising - medwatch.com
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
IO Biotech stock plummets after company explores strategic alternatives By Investing.com - Investing.com Nigeria
IO Biotech stock plummets after company explores strategic alternatives - Investing.com
IO Biotech announces exploration of strategic alternatives - TipRanks
IO mulls more layoffs months after halving head count in wake of cancer vaccine setback - Fierce Biotech
IO Biotech Explores Strategic Alternatives Amid Cost-Cutting Plans - TipRanks
IO Biotech (IOBT) Explores Strategic Alternatives to Maximize Shareholder Value - Intellectia AI
IO Biotech, Inc. Announces Exploration of Strategic Alternatives - TradingView
IO Biotech to explore strategic alternatives - MSN
IO Biotech Announces Exploration of Strategic Alternatives - The Manila Times
IO Biotech Announces Exploration of Strategic Alternatives to Enhance Stockholder Value - Quiver Quantitative
Moderna cancer vaccine holds up; IO Biotech considers a sale - Yahoo Finance
Cancer vaccine developer weighs sale, merger or liquidation - Stock Titan
Market Review: How do insiders feel about SOPAWeekly Stock Report & Real-Time Stock Entry Alerts - baoquankhu1.vn
Market Trends: What is the long term forecast for IO Biotech Inc stockJuly 2025 Momentum & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Valuation Update: Can ALCY lead its sector in growthWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
Jefferies maintains IO Biotech Buy rating, $8 target on PFS hopes - MSN
IO Biotech Faces Existential Threats as Funding and Regulatory Woes Mount - AD HOC NEWS
Aug Shorts: Will IO Biotech Inc outperform tech stocksJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
What margin trends mean for IO Biotech Inc. stockMarket Growth Report & Weekly Setup with High ROI Potential - Bộ Nội Vụ
Sectors Review: Will IO Biotech Inc outperform tech stocks2025 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn
Hedge Fund Moves: Can IO Biotech Inc beat the S P 500GDP Growth & Proven Capital Preservation Tips - baoquankhu1.vn
Published on: 2026-01-10 21:43:17 - Улправда
Wall Street Zen Upgrades IO Biotech (NASDAQ:IOBT) to Hold - Defense World
Will IO Biotech Inc. stock attract ESG investors2025 Breakouts & Breakdowns & Community Consensus Picks - Улправда
Why IO Biotech Inc. stock could benefit from AI revolutionStop Loss & Reliable Trade Execution Plans - Улправда
Morgan Stanley downgrades IO Biotech stock to Underweight on cash concerns By Investing.com - Investing.com South Africa
Morgan Stanley downgrades IO Biotech stock to Underweight on cash concerns - Investing.com Nigeria
IO Biotech, Inc. (NASDAQ:IOBT) Given Average Rating of “Hold” by Analysts - Defense World
Will IO Biotech Inc. stock outperform international peers2026 world cup usa national team semifinals top scorers set piece tactics odds analysis breakdown - ulpravda.ru
How IO Biotech Inc. stock performs during Fed tightening cyclesVolatility Adjusted Trading & Grow Smarter With Pro-Level Research - bollywoodhelpline.com
Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Decreases By 29.2% - MarketBeat
IO Biotech (NASDAQ:IOBT) Stock Rating Lowered by Wall Street Zen - Defense World
Will IO Biotech Inc. stock reach all time highs in 2025Stock Surge & Accurate Intraday Trade Tips - Улправда
How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Reactions & Smart Allocation Stock Tips - Улправда
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):